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ABSTRACT: The present study was carried out in a sample of 30 numbers of female infertility 
cases with the use of phalagritam in the from of intra uterine insuffulation.  After the treatment of 
three consecutive cycles an overall encouraging result was observed which will be represented 
in the full paper. 
 
INTRODUCTION: 
 
Stree bandhyatwa or female infertility a 
gynaecological disorder is not fatal, but 
hinders the of progeny.  The aetiological 
factors include the defect in the union of 
sperm and ovum during fertile period.   
Defect in uterus, cervix and fallopian tube, 
defect in ovulation and defect in hormonal 
function. (Defect in Ritu.  Kshera, Ambu 
and Beeja). 
 
Thirty patients of infertility were taken for 
the present study after proper clinical and 
laboratory investigations, and the cause of 
infertility was traced out. 
 
The trial drug phalaghrita was administered 
in the form of uttaravasti in  a each cycle 
(after cessation of menstrual bleeding ) for 
three successive cycles.  The effectiveness 
was evaluated based upon the cause of 
infertility.  It was revealed that phalagrita 
uttaravasti was having 46.67% effectiveness 
of its cause of female infertility irrespective 
of its cause. 
 
MATERIALS & METHOD: 
This is a controlled single blind clinical trial 
confined only to female infertility and its 
management.  Thirty patients of female 
infertility including both primary and 
secondary were taken by multiphase random 
sampling method and screened according to 
the selection criteria. 
 
Criteria for selection of cases: 
Prior to trial consent was obtained form each 
patient and registered. The criteria applied 
for selection of cases were as follows. 
Married female patients within the age 
group of 20-30 yrs. 
 
a) Subjective criteria 
i) Pain in lower abdomen 
ii) Tenderness in lower abdomen 
iii) Back ache 
iv) Head reelig 
v) Head ache 
vi) Weaknees 
vii) Character, duration and interval of 
menstruation. 
viii) Sexual problems like pain, burning 
sensation discharge and dryness of vagina 
during inter course. 
 
b) Objective criteria 
 
i) Infertility (No conception) 
ii) Ovulation negative 
iii) Blockage of fallopian tubes. 
 
Exclusion criteria: Patients with  
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i) Infertility of age below 20 years and 
above 35 years 
ii) Congential absence or deformities of 
uterus 
iii) Ovarian tumours 
iv)  Cancer of cervix or uterus 
v) Tubectomy 
vi) Diabetes mellitus positive cases. 
vii) V.D.R.L. Positive cases. 
viii) Monutoux positive cases 
ix) Thyrotoxocosis 
 
Were excluded fro the study. 
 
Drug and Dose: 
The trial drug phalaghrita described in 
sharangadhara was prepared by purifying 
(Murchhita) cow’s ghee with triphala, 
musta, haridra and lemon juice.  Then the 
thirteen herbs such as Triphala, sahachara, 
saireyaka, Guduchi, Punarnava, Syonaka, 
Twak, Haridra, Daru haridra, Rasna, Meda 
and Satavari were put into that murchhita 
ghrita, after being cooked with four times 
cows milk and eight times water in ghrita 
paka vidhi.  The prepared drug was 
standardized by physiochemical analysis. 
 
The Trial drug phalaghrita is Ghee based 
herbal preparation.  It is applied locally as 
an intrauterine insuffulation or uttaravasti by 
a specially designed vasti yantra in the dose 
of 3-5 ml day for to total 9 days in three 
months. During the process of uttaravasti 
patients were watched carefully for 
occurance of pain, discomfort or any other 
symptoms.  Complete aseptic measures were 
adopted during the process. 
 
ASSESSMENT: 
Assessment was done in each month upto 3 
consecutive cycles and after three months of 
follow up, the initial finding through 
questionnaire; clinical and pathological 
statements were compared with the result of 
progressive 1
st month 2
nd month, 3
rd month 
and 6
th month.  The clinical assessment was 
made depending upon the changes in 
subjective and objective features such as  
 
1.  Fertility or Amenorrhoea along with 
positive response in preg colour card 
test. 
2.  Ovulation positive by premenstrual 
endometrial biopsy. 
3.  Patency of fallopian tubes by 
hysterosalpingography 
4.  Regulation and relief of associated 
symptom of menstruation  
5.  5. Abolishment of sexual problems 
in intercourse. 
6.  Relief from associated symptoms 
like pain, tenderness in lower 
abdomen, head ache Head reeling, 
back ache and weakness. 
 
The clinical assessment of result was 
being done as cure 100% ,maximum 
improvement 75-99%, moderate 
improvement 50-74%, mild 
improvement 25-49% and no 
improvement < 25% free from signs like 
infertility, unovulator cycles and tubal 
blockage. 
 
OBSERVATION: 
Thirty number of patients having the 
complain of childlessness were taken 
after proper clinical and laboratory 
investigations. All these case were 
thoroughly examined to trace out the 
cause of infertility, and were noted in a 
specially designed case-sheet to follow 
up the ogress during the treatment 
period. 
 
The clinical observation from different 
aspects aspects approaching to the 
treatment for the entire patients had been 
represented showing the incidences 
statical analysis of effectiveness of trial 
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drug along with clinical assessment of 
result. 
 
The incidence of infertility was observed 
that 50% case were within the age group 
of 26-30 yr and had the duration of 
infertility within 1-3 years regarding the 
age of marriage. Occupation and type of 
infertility 46.67% of cases had got 
married within the age of 21-25 yr. 70% 
patients were house wives and 70% 
patients were house wives and 70%cases 
were also of primary infertility, Uterine, 
cervical, Tubal, ovulatory and 
unexplained are being the causes of 
infertility, there were 50% cases with 
uterine cause, 40% with cervical cause, 
30% tubal cause, 16.67 ovulatory cause, 
6.67% unexplained cause. 
 
Regarding the clinical sign and 
symptoms 73.33% of patients had 
weakness 53.33% had pain in lower 
abdomen 43.33% had tenderness in 
lower abdomen and back ache 40% of 
patients had head reeling 36.67% of 
patients were having head ache 
dysmenorrhoea and dryness in vagina 
30% patients had menorrhagia and 
burning sensation in vagina. 20% 
patients had oligmenorrhoea and 
dyspareunia.  
 
After treatment of three months it was 
evident that the clinical sign and 
symptoms indifferent patients which 
were in severe to mild degree were 
relieved abosolutly 100% indicating the 
highly effectiveness of the trial drug.   
Depending upon the cause of infertility 
and its percentage of improvement 
before and after treatment 46.67% of 
patients experienced amenorrhoea 60% 
of patients reported ovulatory cycles and 
50% get relieved from tubal blockage.   
Out of the study the clinical assessment 
as a hole signify the effictiveness of the 
trial drug that favourable results were 
obtained in 60% of cases out of which 
43.33 % cases were cured, 10% were in 
moderate improvement and 6.67% were 
in mild improvement. 
 
The clinical pathological and 
readiological findings on every point 
have statistically analysed and 
configurated with pairedt test inorder to 
prove its significance in scientific 
manner. 
 
Observations regarding the effectiveness 
of trial drug to infertility, its 
investigations and associated sign and 
symptoms was carries out by comparing 
the mean+/-S.D value of each response 
before and sfter treatment.  Finally the 
drug was found significantly effective in 
tubal blockage. And infertility with a P-
value <0.05 and highly significant in all 
other associated sign and symptoms with 
a P- value of <0.01. 
 
DISCUSSION: 
Base pm the observation and result every 
aspects related to the management of 
infertility was discussed scientifically. 
 
Bandhyatwa being a vatic disorder 
demands vasti karma with local snehana 
(soothing effect) and tarpana 
(nourishment of endometrium). So uttara 
vasti with phalaghrita was selected and 
administered keeping in view the above 
factors and textual hypothisis. 
 
Endometrial bipsy was done to ensure 
ovulation. Form endometirum bipsy 5 
patients (16.67%). Were reported non 
secretory endometrium before treatment. 
After treatment one cycle one patient 
had conceived with an evidence of 
ovulation. 
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Hystero salpingography was done to 
evaluate the effect of trial drug on 
blockage of fallopian tube.  From H.S.G.  
9(30%) patient were found with tube 
blockage.  Out of them 3 patients had 
blockage on both the tubes and 6 had 
unilateral blockage.  After treatment of 
one cycle 8.33% of patients were 
reported with conception and after the 
treatment of 3
rd cycle 50% of cases were 
reported with patient fallopian tube.  Out 
of the total cases of blacked fallopian 
tubes 6 patients became pregnant by the 
end of treatment schedule Dr. Cherny et 
al 1998 reported 29% pregnancy when 
an oil based contrest dye was used 
buring H.S.G., compared to 13% 
pregnancy rate with water soluble dye. 
Which suggests the opening of blocked 
tube with oil based dye.  Phalaghritam 
being an oily preparation used 
therapeutically for the treatment of 
infertility.  It is assumed that it might 
have opend the fallopian tube. 
 
Though proper scientific hypothesis 
could not be traced out, three out of five 
number of unovulatory case showed 
ovulation after the treatment with 
phalaghrita.  As regards the other 
symptoms associated with infertility, 
like irregular menstruation lower 
abdominal pain and tenderness, 
dyspareunia; a remarkable improvement 
has been observed in the present study. 
 
CONCLUSION: 
Thus it can be concluded that uttaravasti 
of phalaghrita is definitely an effective 
one in the treatment of infertility.  It has 
also a significant effect on other localize 
complaints like menstrual disorder, 
lower abdominal pain, tenderness and 
dysparenia. Further study on a large 
sample is needed to confirm the efficacy 
of the drug. 
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TABLE NO -1 : PHYSIO-CHEMICAL ANALYSIS OF PHALAGHRITA  
  
TABLE NO -2 : Showing the causes of infertility =30  
No. of patients   Case of 
infertility  Primary Secondry 
Total Percentage 
Uterine 11.(36.67%)  4(13.33%)  15  50% 
Cervical 1o.(33.33%)  2(6.67%)  12  40% 
Tubal 5(16.67%)  4(13.33%) 9  30% 
Ovulatory 5(16.67%)  0  5  16.67% 
Unexplained 13.33%  1(3.33%)  2  6.67% 
 
TABLE NO. -3 : Showing the clinical assessment of result N= 30  
AT(1) AT(2)  AT(3)  Clinical Assessment 
No. of 
Pt. 
% No.  of 
Pt. 
%  No. of Pt.  % 
Cured -  -  -  -  13  43.33 
Maximum  Improvement  -  - - -  - - 
Moderenate 
Improvement 
1 3.33  5 16.67  3  10 
Mild 
Improvement 
- -  1  3.33 2  667 
No.  improvement  29  96.67  24 24  12 40 
 
1
. 
Colour Greenish 
Yellow 
7.  Refractive index at 40o  1.453 
2
. 
Smell Fragrant  8.  Ash  value  0.03%w/w 
3
. 
Touch Greasy  9.  Acid  value  1.99 
4
. 
Taste  Astringent  10.  Saponification value   223.40 
5
. 
Loss on during at 110oC  0.43% w/w  11.  Iodine  38.41 
6
. 
Volatile oil  0.34% w/w  12.  Total fat  97.43 
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